Sildenafil Prevents Apoptosis of Human First-Trimester Trophoblast Cells Exposed to Oxidative Stress Possible Role for Nitric Oxide Activation of 3′,5′-cyclic Guanosine Monophosphate Signaling

Human first-trimester trophoblast cells proliferate at low O2, but survival is compromised by oxidative stress, leading to uteroplacental insufficiency. The vasoactive drug, sildenafil citrate (Viagra, Sigma, St Louis, Missouri), has proven useful in reducing adverse pregnancy outcomes. An important...

Full description

Saved in:
Bibliographic Details
Published inReproductive sciences (Thousand Oaks, Calif.) Vol. 22; no. 6; pp. 718 - 724
Main Authors Bolnick, Jay M., Kilburn, Brian A., Bolnick, Alan D., Diamond, Michael P., Singh, Manvinder, Hertz, Michael, Dai, Jing, Armant, D. Randall
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.06.2015
Springer International Publishing
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human first-trimester trophoblast cells proliferate at low O2, but survival is compromised by oxidative stress, leading to uteroplacental insufficiency. The vasoactive drug, sildenafil citrate (Viagra, Sigma, St Louis, Missouri), has proven useful in reducing adverse pregnancy outcomes. An important biological function of this pharmaceutical is its action as an inhibitor of cyclic guanosine monophosphate (cGMP) phosphodiesterase type 5 activity, which suggests that it could have beneficial effects on trophoblast survival. To investigate whether sildenafil can prevent trophoblast cell death, human first-trimester villous explants and the HTR-8/SVneo cytotrophoblast cell line were exposed to hypoxia and reoxygenation (H/R) to generate oxidative stress, which induces apoptosis. Apoptosis was optimally inhibited during H/R by 350 ng/mL sildenafil. Sildenafil-mediated survival was reversed by l-NG-nitro-l-arginine methyl ester hydrochloride or cGMP antagonist, indicating a dependence on both nitric oxide (NO) and cGMP. Indeed, either a cGMP agonist or an NO generator was cytoprotective independent of sildenafil. These findings suggest a novel intervention route for patients with recurrent pregnancy loss or obstetrical placental disorders.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1933-7191
1933-7205
DOI:10.1177/1933719114557894